Skip to main content
Analysts' Upgrades, Downgrades: Broadcom

Analysts' Upgrades, Downgrades: Broadcom

See who made what calls.
  • Author:
  • Publish date:

See who made what calls.

Change in Ratings

Altera

(ALTR) - Get Free Report

downgraded at Goldman Sachs to Sell from Neutral due to reduced capital spending expectations in communications infrastructure market. Note deterioration in emerging markets resulting from slowdown in subscriber growth and other macroeconomic effects. Price target lowered to $16 from $20.

Aon

(AOC)

upgraded at Merrill to Buy. $46 price target. Company does not face near-term liquidity issues, and could grow in the reinsurance market.

Invitrogen

(IVGN)

upgraded at Deutsche Bank from Hold to Buy. $32 price target.

PMC-Sierra

(PMCS)

upgraded at Goldman Sachs to Buy from Neutral based on stabilizing telecom and storage business. Price target lowered to $6 from $7.

Xilinx

(XLNX) - Get Free Report

downgraded at Goldman Sachs to Neutral from Buy due to fundamental headwinds related to weakness in emerging markets wireless infrastructure. Price target cut to $22 from $28.

Stock Comments/EPS Changes

Broadcom

undefined

numbers cut at Morgan Stanley. Shares now seen reaching $16. Estimates also lowered. Equal-weight rating.

Strategy Calls/Market Calls

Morgan Stanley starts coverage on four exchanges.

IntercontinentalExchange

(ICE) - Get Free Report

was initiated with an Overweight rating. Coverage of

CME Group

(CME) - Get Free Report

and

Nasdaq

undefined

were rated Equal-weight, and

NYSE Euronext

(NYX)

as Underweight. Expect declines across the board following the market crisis in 2008. Cautious industry view.

This article was written by a staff member of TheStreet.com.